2 completed, 1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Inert Compound: new trials by email Literature Review of Inert Compound trials Research Report on Inert Compound
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Synbiotic Compound to Reduce Symptoms of Schizophrenia Synbiotic Supplement, Inert Compound - Schizophrenia, Schizoaffective Disorder | Phase 2 | Recruiting | Sheppard Pratt Health System | 68 | 2022-02-21 | 2026-04-07 |
| Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression Probiotic Supplement, Inert Compound - Bipolar Depression | Phase 2 | Active not recruiting | Sheppard Pratt Health System | 80 | 2018-12-11 | 2026-04-07 |
| Probiotics to Prevent Relapse After Hospitalization for Mania Probiotic Supplement, Inert Compound - Bipolar Disorder, Schizoaffective Disorder | Not applicable | Completed | Sheppard Pratt Health System | 66 | 2012-11-01 | 2019-01-07 |
| Psyllium Fiber Versus Placebo in Early Treatment After STARR for Obstructed Defecation: a Double-blind RCT Psyllium fiber, Placebo - Constipation, Incontinence | Phase 4 | Completed | Francesco Gabrielli | 65 | 2010-05-01 | 2014-05-13 |
Bipolar Disorder (2) · Psychotic Disorders (2) · Constipation (1) · Mania (1) · Schizophrenia (1)
Sheppard Pratt Health System (3) · Francesco Gabrielli (1)
United States (3) · Italy (1)
Faith Dickerson, PhD, MPH (3) · Francesco Gabrielli, Prof. (1)